Taubman Institute to appoint six new scholars in 2014
Six new Taubman Scholars -- clinician-scientists selected from among the University of Michigan Medical School faculty -- will be appointed in 2014 by the A. Alfred Taubman Medical Research Institute.
Taubman Scholar grants provide $150,000 per year for three years for these select physician researchers, who combine an active clinical practice with basic laboratory science seeking new treatments and cures for the diseases they treat. The grants are intended to fund the "high risk, high reward" research that often is overlooked by traditional sources of financial support. In the five years since the institute's inception, the research of Taubman Scholars and Taubman Emerging Scholars has led to nearly three dozen human clinical trials of new drugs and therapies for diseases ranging from cancer to muscular dystrophy to ALS.
Prospective scholars must hold an M.D. degree and have until Dec. 1 to complete the application form, which will be vetted by the institute's scientific advisory board, a panel comprised of eminent medical scientsists from outside the university. Click here for complete details and the application form.
10 Taubman Scholars named to "Best Doctors in America" list
They're among 493 U-M physicians to receive the honor from their peers
Click here for the list.
People who care
ALS Association Michigan Chapter honors institute
Founder A. Alfred Taubman and Director Dr. Eva Feldman to receive inaugural award at April 3 gala
Click here for details
U-M offers new early detection prostate cancer test
Research by Taubman Scholar Dr. Arul Chinnaiyan has let to the development of a new test for prostate cancer that is far more accurate than the standard PSA test, the University of Michigan has announced.
Click here to read more.
news & events
New Taubman Prize trophy debuts
The new trophy for the Taubman Prize for Excellence in Translational Medical Research, which was designed in consultation with institute founder Mr. A. Alfred Taubman, was presented at the institute's Oct. 11 symposium. The modern sculpture was created using a novel 3D printing technique.
Drug cuts risk of bone-marrow transplant side effect
Taubman Emerging Scholar Sung Won Choi, M.D., is the lead author of a new study that finds a new way to help prevent graft-vs-host disease in cancer patients receiving bone-marrow transplants.
Study: Two types of cancer stem cells lead to metastasis
Breast cancer stem cells exist in two different states and each state plays a role in how cancer spreads, according to a new study published by Taubman Senior Scholar Dr. Max Wicha.